产品名称：Anti-AKT1+2+3抗体

Cat. Number:

YB6951R

Quantity size:

0.1ml

Concentration:

Anti-AKT1+2+3抗体1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

AKT, also known as protein kinase B (PKB), is a 57 kDa serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from Anti-AKT1+2+3抗体the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold; overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus.

Also known as:

Anti-AKT1+2+3抗体pan-AKT; pan AKT; AKT1 + AKT2 + AKT3; AKT1+AKT2+AKT3; AKT1/AKT2/AKT3; AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; AKT 2; AKT2; AKT-2; AKT2_HUMAN; AKT 3; AKT3; AKT-3; AKT3_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PKB beta; PKB gamma; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1.

Specificity:

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Anti-AKT1+2+3抗体WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  Flow-Cyt=1:50-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.(Human)
yb536Hu01 内皮细胞粘附分子(ESAM)多克隆抗体 Polyclonal Antibody to Endothelial Cell Adhesion Molecule (ESAM) Homo sapiens (Human)
yb544Hu01 细胞粘附分子1(CADM1)多克隆抗体 Polyclonal Antibody to Cell Adhesion Molecule 1 (CADM1) Homo sapiens (Human)
yb562Mu01 TATA框结合蛋白关联因子12(TAF12)多克隆抗体 Polyclonal Antibody to TATA Box Binding Protein Associated Factor 12 (TAF12) Mus musculus (Mouse)
yb563Hu01 TATA框结合蛋白关联因子13(TAF13)多克隆抗体 Polyclonal Antibody to TATA Box Binding Protein Associated Factor 13 (TAF13) Homo sapiens (Human)
yb564Hu01 Tafazzin蛋白(TAZ)多克隆抗体 Polyclonal Antibody to Tafazzin (TAZ) Homo sapiens (Human)
yb569Ra01 酶原颗粒膜糖蛋白(GP2)多克隆抗体 Polyclonal Antibody to Glycoprotein 2, Zymogen Granule Membrane (GP2) Rattus norvegicus (Rat)
yb570Hu01 α1-B-糖蛋白(α1BG)多克隆抗体 Polyclonal Antibody to Alpha-1-B-Glycoprotein (a1BG) Homo sapiens (Human)
yb571Hu01 卷曲同源物1(FZD1)多克隆抗体 Polyclonal Antibody to Frizzled Homolog 1 (FZD1) Homo sapiens (Human)
yb576Hu01 卷曲同源物6(FZD6)多克隆抗体 Polyclonal Antibody to Frizzled Homolog 6 (FZD6) Homo sapiens (Human)
yb593Hu01 泛素关联蛋白2(UBAP2)多克隆抗体 Polyclonal Antibody to Ubiquitin Associated Protein 2 (UBAP2) Homo sapiens (Human)
yb594Hu01 泛素结合酶E2C(UBE2C)多克隆抗体 Polyclonal Antibody to Ubiquitin Conjugating Enzyme E2C (UBE2C) Homo sapiens (Human)
yb624Mu01 周期素依赖性激酶抑制因子1A(CDKN1A)多克隆抗体 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 1A (CDKN1A) Mus musculus (Mouse)
yb624Ra01 周期素依赖性激酶抑制因子1A(CDKN1A)多克隆抗体 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 1A (CDKN1A) Rattus norvegicus (Rat)